When breast cancer returns after treatment or spreads beyond the breast, patients and their families may face a new set of questions. What does this mean for treatment? Which parts of the body can be affected? And what happens next?

In hormone receptor-positive (HR-positive) breast cancer, the cancer cells have receptors for oestrogen, progesterone or both. These hormones can encourage cancer cells to grow. As the disease advances, it may spread to distant organs or stop responding to a treatment that previously controlled it.

Although advanced breast cancer needs ongoing care, several treatment options can help slow its growth, manage symptoms and support quality of life.

Key Takeaways

  • HR-positive breast cancer can metastasise to bone, liver, lung and brain.
  • Palbociclib can be used in combination with endocrine therapy for certain forms of advanced HR positive breast cancer.
  • Blood tests and regular follow-up will be used to monitor treatment response and any side effects.
  • Supportive and palliative care can help manage symptoms and improve quality of life.

What happens when HR-positive breast cancer spreads?

Breast cancer can spread when cancer cells break away from the original tumour and travel through the blood or lymphatic system. They may then settle in another part of the body and form a new tumour. This process is called metastasis.

Advanced HR-positive breast cancer commonly spreads to the bones, liver, lungs or brain. Symptoms depend on where the cancer has spread. Bone involvement may cause persistent pain, while liver involvement can sometimes lead to abdominal discomfort or jaundice. Lung involvement may cause breathlessness or a persistent cough. Brain metastases can cause headaches, seizures or changes in vision.

Not everybody will have symptoms (particularly in the early stages of metastatic disease). Discuss any new or emerging symptoms with your treating doctor rather than assuming they are due to the cancer.

An important point to bear in mind is that breast cancer is still breast cancer if it has spread to another organ. If it's spread to the bone, for instance, the cells in the bone are still breast cancer cells; they're not bone cancer. That distinction matters for what treatment the doctor can offer.

Why can breast cancer return or stop responding to treatment?

HR-positive breast cancer can come back months or years after initial treatment. Some cancer cells may survive treatment and remain dormant for a period before growing again.

Cancer cells can also evolve. Some may become less hormone-dependent, some may have alterations in the growth pathways, and some may become resistant to medications that previously had worked. That's why a treatment that previously controlled the disease may stop being effective.

When cancer progresses, doctors may recommend fresh imaging or a biopsy of a metastatic site, if feasible.

What happens after advanced breast cancer is diagnosed?

Treatment is dictated by where the cancer has spread, the previous treatments that have been given, the symptoms, the characteristics of the tumour and the patient's overall health. The aim is generally to control the disease for as long as possible and help the individual continue their normal day-to-day activities and maintain their quality of life.

For HR-positive breast cancer, treatment often includes endocrine therapy, which reduces the body's oestrogen production or blocks the hormone's effects on cancer cells. However, endocrine therapy may not be enough on its own, particularly when cancer has progressed or developed resistance.

Doctors may combine endocrine therapy with targeted medicines that act on specific proteins involved in cancer cell growth. For example, Paleno 125mg contains palbociclib and is a targeted therapy (a CDK4/6 inhibitor) that works by blocking the CDK4 and CDK6 proteins, which are involved in controlling cell division. It inhibits these proteins and slows the proliferation of certain breast cancer cells.

What other care may be needed?

Treatment is about more than controlling tumour growth. Supportive care can help the patient to manage their symptoms and deal with the practicalities of having advanced cancer.

  • Bone health: if the cancer has metastasised to the bone, then the doctor may consider bone-strengthening medication and look at the risk of fracture.
  • Pain management: pain relief, radiotherapy or other such interventions may be used to help with the pain associated with cancer in a particular site.
  • Nutrition and activity: sufficient nutrition and physical activity appropriate to the individual's abilities will help to maintain strength and daily function.
  • Emotional support: counselling, support groups and just talking to family and friends can all be of immense help in dealing with the uncertainty and the stress of treatment.

What should patients expect during follow-up?

Advanced breast cancer care often involves regular appointments, blood tests and scans. These help doctors assess whether treatment is working and identify side effects that need attention.

If it progresses, then the next step isn't necessarily the same for everyone. Depending on the clinical picture, the oncologist may recommend another endocrine-based combo, a different targeted agent, chemotherapy, or a clinical trial.

Patients should tell their healthcare team about new symptoms, changes in daily functioning or side effects that interfere with eating, sleeping or routine activities. Keeping a record of symptoms and questions before appointments can make these conversations easier.

Conclusion

A diagnosis of advanced HR-positive breast cancer can bring uncertainty, but it does not mean that treatment options have run out. Understanding where the cancer has spread, how its biology may have changed and which treatments remain suitable helps doctors plan the next steps. With regular monitoring, appropriate treatment and supportive care, the focus remains on controlling the disease and helping patients live as well as possible.

Disclaimer: This article is intended for general health information and should not replace professional medical advice. Treatment decisions for advanced breast cancer should be made with a qualified oncologist. Do not start, stop or change any medicine without consulting your healthcare professional.